-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q+SCFgrmyh/XlMNcSW93Mq4psO+1RqeRiSnyXAzcFBUoA330xoPaITlFctRQihm8 N1vSkohVh/SM1JpumM4hSg== 0001301800-09-000002.txt : 20090814 0001301800-09-000002.hdr.sgml : 20090814 20090814153140 ACCESSION NUMBER: 0001301800-09-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090814 DATE AS OF CHANGE: 20090814 EFFECTIVENESS DATE: 20090814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TyRx Pharma Inc CENTRAL INDEX KEY: 0001301800 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-68851 FILM NUMBER: 091015349 BUSINESS ADDRESS: STREET 1: 1 Deer Park Drive STREET 2: Suite G CITY: Monmouth Junction STATE: NJ ZIP: 08852 BUSINESS PHONE: 732-246-8676 MAIL ADDRESS: STREET 1: 1 Deer Park Drive STREET 2: Suite G CITY: Monmouth Junction STATE: NJ ZIP: 08852 D 1 primary_doc.xml X0502 D LIVE 0001301800 TyRx Pharma Inc 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 732-246-8676 Advanced Materials Design, LLC Advanced Materials Design, Inc. DELAWARE Corporation true William Edelman 1 Deerpark Drive Suite G Monmouth Junction NJ 08852 Executive Officer Director Arikha Moses 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 Executive Officer Ray Imp 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 Executive Officer Charles Cahn 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 Director Arthur Pappas 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 Director Jeff Leiden 1 Deer Park Drive Suite G Monmouth Junction NJ 08852 Director Scott Requadt 1 Deerpark Drive Suite G Monmouth Junction NJ 08852 Director Mike Heffernan 1 Deerpark Drive Suite G Monmouth Junction NJ 08852 Director William G. Dempsey 1 Deerpark Drive Suite G Monmouth Junction NJ 08852 Director Other Decline to Disclose 06 false 2009-07-27 false true true true Unsecured Convertible Promissory Notes and Warrants false 125956 11000000 11000000 0 The investors agreed to invest an aggregate of $6,500,000 at the Initial Closing and an additional $4,500,000 upon the attainment of certain milestones by the Issuer. false 6 0 0 0 false TyRx Pharma Inc Ray Imp Ray Imp Chief Financial Officer 2009-08-14 -----END PRIVACY-ENHANCED MESSAGE-----